Disrupted in Renal Carcinoma 3 (DIRC3) impacts malignant phenotype and IGFBP5/IGF-1/Akt signaling axis in differentiated thyroid cancer. https://www.biorxiv.org/content/10.1101/2023.01.24.525402v1?med=mas
Disrupted in Renal Carcinoma 3 (DIRC3) impacts malignant phenotype and IGFBP5/IGF-1/Akt signaling axis in differentiated thyroid cancer. https://www.biorxiv.org/content/10.1101/2023.01.24.525402v1?med=mas